back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-08-15 Tx date 2018-07-18 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Holder: Dawn Tam (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-627,200 vol |
44,800 | |
| Filed 2018-08-15 Tx date 2018-07-18 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Holder: Cyto IQ Biomedical Corp. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-12,362,045 vol |
883,003 | |
| Filed 2018-08-15 Tx date 2018-07-18 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Holder: Alan Tam ITF Elizabeth Tam (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-62,223 vol |
4,444 | |
| Filed 2018-08-15 Tx date 2018-07-18 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,507,600 vol |
393,400 | |
| Filed 2018-06-01 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Stephania A. J. Romaniuk (TFSA) (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-01 Tx date 2018-06-01 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Stephania A. J. Romaniuk (TFSA) (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
$26,308
+194,880 vol $0.135 each |
194,880 | |
| Filed 2018-04-26 Tx date 2018-04-26 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,500
-100,000 vol $0.135 each |
5,901,000 | |
| Filed 2018-03-19 Tx date 2018-03-19 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,700
-60,000 vol $0.145 each |
6,001,000 | |
| Filed 2018-02-28 Tx date 2018-02-13 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-8,222.40
-45,680 vol $0.18 each |
194,880 | |
| Filed 2018-02-28 Tx date 2018-02-13 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Bohdan S. Romaniuk (TFSA) (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$8,222
+45,680 vol $0.18 each |
228,346 | |
| Filed 2018-02-28 Tx date 2018-02-13 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Bohdan S. Romaniuk (RRSP) (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$45,000
+250,000 vol $0.18 each |
427,419 | |
| Filed 2018-02-28 Tx date 2018-02-13 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-45,000
-250,000 vol $0.18 each |
240,560 | |
| Filed 2017-01-10 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Barbara J. Romaniuk (RRSP) (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
155,221 | ||
| Filed 2017-01-10 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
490,560 | ||
| Filed 2017-01-10 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: 944133 Alberta Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2017-01-10 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Bohdan S. Romaniuk (RRSP) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
177,419 | ||
| Filed 2017-01-10 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Romaniuk, Bohdan S.
4 - Director of Issuer
Holder: Bohdan S. Romaniuk (TFSA) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
182,666 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,117,500 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tsui, Norman
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Norman Tsui ITF Ethan Tsui (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
586,667 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tsui, Norman
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Norman Tsui ITF Brianna Tsui (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
586,667 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tsui, Norman
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,323,200 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Holder: Szu Min Chiu ITF Magnus Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
33,333 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Holder: Szu Min Chiu ITF Ayden Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
33,333 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Holder: Percy G.K. Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
108,900 | ||
| Filed 2017-01-06 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Neweduk, Peter Micheal
4 - Director of Issuer
Holder: ITF Natasha Neweduk (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,333 | ||
| Filed 2017-01-06 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Neweduk, Peter Micheal
4 - Director of Issuer
Holder: William Neweduk (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
66,000 | ||
| Filed 2017-01-06 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Neweduk, Peter Micheal
4 - Director of Issuer
Holder: RESP Natasha and Anneliese Neweduk (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,460 | ||
| Filed 2017-01-06 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Neweduk, Peter Micheal
4 - Director of Issuer
Holder: Lynnett Darrell (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
36,333 | ||
| Filed 2017-01-06 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Neweduk, Peter Micheal
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,047,896 | ||
| Filed 2017-01-05 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,061,000 | ||
| Filed 2017-01-05 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Nerland, Dennis Leroy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,401,817 | ||
| Filed 2017-01-05 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Holder: Alan Tam ITF Elizabeth Tam (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
66,667 | ||
| Filed 2017-01-05 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Holder: Cyto IQ Biomedical Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,245,048 | ||
| Filed 2017-01-05 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Tam, Alan Shui Yan
5 - Senior Officer of Issuer
Holder: Dawn Tam (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
672,000 |